Acta Scientific Microbiology (ISSN: 2581-3226)

Case Report Volume 4 Issue 6

Gastric Mucormycosis by Rhizopus microsporus in a Patient with Uncontrolled Diabetes Mellitus

Gitali Bhagawati1*, Mahesh Gupta2, Sania Paul1, Rekha Saji Kumar1 and Lincy3

1Gastric Mucormycosis by Rhizopus microsporus in a Patient with Uncontrolled Diabetes Mellitus
2Department of Gastroenterology, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India
3Department of Infection Control, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India

*Corresponding Author: Gitali Bhagawati, Department of Microbiology, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India.

Received: April 26, 2021 ; Published: May 17, 2021


Mucormycosis is a rapidly progressive life-threatening angio-invasive fungal infection caused by ubiquitous filamentous fungi of the order Mucorales and class Zygomycetes. The disease spectrum ranges from involvement of sinuses, lung, brain and skin to disseminated fatal infections, especially in immunocompromised hosts. Cases of primary gastric mucormycosis are rare in literature. It can be lethal due to invasion of gastric mucosa by Mucorales. High index of clinical suspicion in patient coming with haematemesis and melena with immunocompromised status can help in early intervention. Common risk factor for gastrointestinal mucormycosis (GIM) has been found to be uncontrolled DM with and without diabetic ketoacidosis (DKA). Here, we are presenting a case of 48 year male patient diagnosed with mucormycosis of gastric fundus coming with history of melena of one week duration and single episode of haematemesis. The patient had uncontrolled DM and was on oral hypoglycemic agent. Fungal culture showed growth of Mucor. Morphology of the fungal colonies as well as microscopic examination of the fungus confirmed it as Rhizopus spp. Fungal colonies were sent for further confirmation by molecular sequencing to reference laboratory. Species level identification was done by ITS1-5.8S-ITS2 rRNA gene cluster internal transcribed spacer [ITS] sequencing. Sequencing confirmed the fungus as Rhizopus microsporus. The patient was put on intravenous Amphotericin-B; but was stopped in view of renal function derangement. Later Posaconazole was added and patient responded completely.

Keywords: Zygomycetes; Rhizopus microspores; Gastrointestinal Mucormycosis; Immunocompromised


  1. Hibbett DS., et al. “A higher-level phylogenetic classification of the Fungi”. Mycological Research 111 (2007): 509-547.
  2. Dikshya Sharma., et al. “Case of early-disseminated Rhizopus microsporus microsporus mucormycosis in a renal transplant patient”. International Medical Case Reports Journal 9 (2016): 139-143.
  3. Prakash H and Chakrabarti A. “Global Epidemiology of Mucormycosis”. Journal of Fungi (Basel)1 (2019): 26.
  4. A Serris., et al. “Disease entities in mucormycosis”. Journal of Fungi1 (2019): 23.
  5. Salwa O Mekki., et al. “Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems”. Case Reports in Pathology 2020 (2020): 5845394.
  6. Kaur H., et al. “Gastrointestinal mucormycosis in apparently immunocompetent hosts—A review”. Mycoses 61 (2018): 898-908.
  7. Kontoyiannis DP and Lewis RE. “Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management”. Infectious Disease Clinics of North America 20 (2006): 581-607.
  8. Epifanio Silvino do Monte Junior., et al. “Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report”. Clinical Endoscopy6 (2020): 746-749.
  9. Maraví-Poma E., et al. “Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients”. Intensive Care Medicine4 (2004): 724-728.
  10. Shiva Prasad BN., et al. “Primary gastrointestinal mucormycosis in an immunocompetent person”. Journal of Postgraduate Medicine 54 (2008): 211-213.
  11. Spellberg B. “Gastrointestinal mucormycosis: an evolving disease”. Gastroenterology and Hepatology (N Y) 8 (2012): 140-142.
  12. Maureen M Roden., et al. “Epidemiology and outcome of zygomycosis: a review of 929 reported cases”. Clinical Infectious Diseases 5 (2005): 634-653.
  13. A Vera., et al. “Invasive gastrointestinal zygomycosis in a liver transplant recipient”. Transplantation 73.1 (2002): 145-147.
  14. Chakrabarti A., et al. “The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus”. Medical Mycology 4 (2006): 335-342.


Citation: Gitali Bhagawati., et al. “Gastric Mucormycosis by Rhizopus microsporus in a Patient with Uncontrolled Diabetes Mellitus”. Acta Scientific Microbiology 4.6 (2021): 40-44.


Copyright: © 2021 Gitali Bhagawati., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor0.614

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US